March 3, 2010 – Research Triangle Park, NC — Advanced Animal Diagnostics (AAD) has strengthened its leadership team with the additions of a financial industry veteran and a leader in healthcare executive management to its Board of Directors. Gary Greenbaum and Robert Hannan will both serve on the Board of Directors of the innovative R&D company that is working to bring highly accurate, rapid diagnostic tests to the farm.
“Gary and Bob each bring tremendous experience and expertise and we look forward to their contributions to the Board of Directors,” said Charlie Galanaugh, chairman of the board, AAD.
Charlie Galanaugh and Rudy Rodriguez, founder and chief scientific officer of AAD, have both been re-elected to the company’s Board of Directors.
Gary Greenbaum was the president of Greenbaum and Orecchio, Inc., a wealth management firm that provided investment advisory services to 225 clients in 21 states. He founded the firm in 1982 and sold his shares to his three partners in 2008 after 26 years in the business. Greenbaum was named one of the top 100 Wealth Advisors in the nation by Worth Magazine in 2007 and a Reuters AdvisePoint Top Advisor in 2008. In addition, Greenbaum and Orecchio, Inc. has been named one of the leading wealth management firms in the nation for the last eight consecutive years by Wealth Manager Magazine.
Greenbaum has served in leadership and board positions for a number of industry and professional organizations, including National Association of Personal Financial Advisors, Investment Management Consultants Association, the CFA Institute, and the New York Society of Securities Analysts, among others. Greenbaum has also served as an adjunct faculty member at Lubin Graduate School of Business, The New School for Social Research and Pace University.
Robert Hannan brings more than 30 years of executive management, marketing and business development experience in the health care industry to the AAD Board of Directors. He started his career in advertising with BBDO and William Esty focusing on the packaged goods industry, then moved to a variety of marketing, management and new venture positions at Glaxo Smith Kline and Becton Dickinson. In 1981, he founded the consulting firm, The Genesis Group, and served as managing partner/CEO until 2000. The firm managed hundreds of strategic management and new business assignments for some of the leading names in the healthcare (diagnostic/molecular device), pharmaceutical and biotech industries. He also founded several widely distributed healthcare publications addressing the business implications of technology innovation (The Genesis Report/Rx, The Genesis Report/Dx, The Genesis Report/MCx, and the Genesis Report Molecular and Genetic Medicine), as well as the strategic management publishing firm POV® Incorporated.
Hannan’s firms were acquired by Wolters Kluwer in 2000, and he served as general manager of this group, then head of the Worldwide Business Intelligence Group until 2002. He now resides in Prince George, SC, and serves as a board member and/or strategic advisor to a number of venture groups and early stage healthcare firms.
Listed in all major editions of Who’s Who, Hannan is also a member of both the American Association for the Advancement of Science and the New York Academy of Science. Hannan completed his undergraduate work at John Carroll and his MBA at Rutgers Graduate School of Management. He completed post-graduate study in strategy formulation through several corporate assignments at leading graduate business schools.
Advanced Animal Diagnostics (AAD) was founded in 2001 to commercialize exclusively licensed proprietary technology for the diagnosis of farm-animal diseases, beginning with those that affect milk and milk products. In addition, the company has also developed intellectual property internally, which will have many applications in farms and veterinary medicine. AAD is located at 1912 HWY 54 East, Durham, NC 27713. For more information about Advanced Animal Diagnostics, please visit www.advancedanimaldiagnostics.com.